Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 100

4,194.00p
   
  • Change Today:
      68.00p
  • 52 Week High: 5,405.00
  • 52 Week Low: 3,272.00
  • Currency: UK Pounds
  • Shares Issued: 108.36m
  • Volume: 177,640
  • Market Cap: £4,544.82m
  • RiskGrade: 121
  • Beta: 0.03

Director dealings: Dechra director makes share sale

By Iain Gilbert

Date: Monday 13 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Dechra Pharmaceuticals revealed on Monday that director Tony Griffin had sold 17,500 ordinary shares in the FTSE 250-listed veterinary drugmaker.
Griffin, who was appointed managing director of DVP EU in May 2012 following the acquisition of Eurovet Animal Health, sold the shares on Friday at an average price of 5,001.49p each, for a total value of £875,261.09.

Following the sale, Griffin holds 28,150 ordinary shares in the group, which represents 0.026% of Dechra's current issued share capital.

As of 1625 BST, Dechra shares were down 1.05% at 4,922.0p.

Top Director Buys

Altitude Group (ALT)
Director name: Varley,Martin Roy
Amount purchased: 39,336 @ 36.70p
Value: £14,436.31

Uls Technology (ULS)
Director name: Scott,Oliver Rupert Andrew
Amount purchased: 15,000 @ 78.00p
Value: £11,700.00

Galantas Gold Corp. (GAL)
Director name: Stifano,Mario
Amount purchased: 30,500 @ $0.48
Value: $8,697.28

Aew Uk Reit (AEWU)
Director name: Sandhu,Bimaljit S (Bim)
Amount purchased: 5,839 @ 107.40p
Value: £6,271.09

Krm22 (KRM)
Director name: Todd,Thomas Keith
Amount purchased: 1,900 @ 24.20p
Value: £459.80

Croda International (CRDA)
Director name: Foots,Steve
Amount purchased: 2 @ 9,230.00p
Value: £184.60

Croda International (CRDA)
Director name: Brophy ,Tom
Amount purchased: 2 @ 9,230.00p
Value: £184.60

Sabre Insurance Group (SBRE)
Director name: Carter,Geoffrey Richard
Amount purchased: 69 @ 218.02p
Value: £150.43

Firstgroup (FGP)
Director name: Mangold,Ryan
Amount purchased: 170 @ 88.44p
Value: £150.35

Meggitt (MGGT)
Director name: Wood,Tony
Amount purchased: 20 @ 730.86p
Value: £146.17

Croda International (CRDA)
Director name: Maiden,Jez K
Amount purchased: 1 @ 9,230.00p
Value: £92.30



Top Director Sells

Dechra Pharmaceuticals (DPH)
Director name: Griffin ,Tony
Amount sold: 17,500 @ 5,001.49p
Value: £875,261.09

The Gym Group (GYM)
Director name: Treharne,John
Amount sold: 250,000 @ 280.83p
Value: £702,075.00

The Gym Group (GYM)
Director name: Treharne,John
Amount sold: 250,000 @ 279.57p
Value: £698,925.02

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DPH Market Data

Currency UK Pounds
Share Price 4,194.00p
Change Today 68.00p
% Change 1.65 %
52 Week High 5,405.00
52 Week Low 3,272.00
Volume 177,640
Shares Issued 108.36m
Market Cap £4,544.82m
Beta 0.03
RiskGrade 121

DPH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.1% below the market average99.1% below the market average99.1% below the market average99.1% below the market average99.1% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
17.58% above the market average17.58% above the market average17.58% above the market average17.58% above the market average17.58% above the market average
23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average
Income
85.87% below the market average85.87% below the market average85.87% below the market average85.87% below the market average85.87% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Growth
82.67% above the market average82.67% above the market average82.67% above the market average82.67% above the market average82.67% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 5
Sell 0
Strong Sell 1
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DPH Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Oct-21 04-Mar-21
Paid 19-Nov-21 07-Apr-21
Amount 29.39p 11.11p

Trades for 20-Jan-2022

Time Volume / Share Price
16:35 229 @ 4,194.00p
16:35 63,096 @ 4,194.00p
16:29 2 @ 4,190.00p
16:29 65 @ 4,186.00p
16:29 21 @ 4,192.00p

DPH Key Personnel

CEO Ian Page
CFO Paul Sandland

Top of Page